Y-Intercept (HK)’s 10x Genomics TXG Stock Holding History

Y-Intercept (HK)’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$941K	Buy	+24,543	New	+$643K	0.02%	1074
2026 Q1	–	Sell	-20,922	Closed	-$341K	–	2070
2025 Q4	$341K	Buy	+20,922	New	+$316K	0.01%	1344
2025 Q3	–	Sell	-81,290	Closed	-$941K	–	2061
2025 Q2	$941K	Buy	+81,290	New	+$741K	0.02%	967
2025 Q1	–	Sell	-17,305	Closed	-$249K	–	1621
2024 Q4	$249K	Sell	17,305 -485	-3%	-$7.65K	0.02%	992
2024 Q3	$402K	Buy	+17,790	New	+$368K	0.02%	883
2024 Q1	–	Sell	-9,884	Closed	-$553K	–	1772
2023 Q4	$553K	Buy	+9,884	New	+$430K	0.05%	548
2023 Q3	–	Sell	-13,356	Closed	-$746K	–	1619
2023 Q2	$746K	Sell	13,356 -11,351	-46%	-$614K	0.08%	397
2023 Q1	$1.38M	Buy	+24,707	New	+$1.15M	0.16%	173
2022 Q1	–	Sell	-1,533	Closed	-$228K	–	960
2021 Q4	$228K	Buy	+1,533	New	+$235K	0.05%	477
2021 Q1	–	Sell	-2,469	Closed	-$352K	–	807
2020 Q4	$352K	Buy	+2,469	New	+$358K	0.15%	258

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

TWM

TriaGen Wealth Management Calabasas, California $400M AUM 39.13% 1-Year Est. Return

VWM

Venturi Wealth Management Austin, Texas $2.58B AUM 41.25% 1-Year Est. Return

Y-Intercept (HK)'s TXG Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in 10x Genomics (TXG) in Q2 2026: 24,543 shares worth $941K. The stake represents 0.02% of the portfolio and ranks #1074 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in TXG as recently as Q4 2025.

Y-Intercept (HK) first reported a position in TXG in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.38M in Q1 2023. 44 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Y-Intercept (HK) held 24,543 shares of 10x Genomics worth $941K as of Q2 2026.
10x Genomics was a new Y-Intercept (HK) position in Q2 2026.
10x Genomics made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1074 holding.
Y-Intercept (HK) first reported a position in 10x Genomics in Q4 2020 and has held it in 10 quarters since.
Y-Intercept (HK)'s 10x Genomics position peaked at $1.38M in Q1 2023.
44 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.